Investment Firms in Basel, Switzerland
Situated within the trinational Upper Rhine region, it is a globally significant hub for life sciences and industrial biotechnology, heavily influenced by the presence of major pharmaceutical corporations. This deep industry expertise anchors a venture capital ecosystem that is particularly specialized in supporting high-growth, late-stage companies in biotech and related sectors. Its strength is further amplified by close collaboration with local universities and research institutes, which provide a steady pipeline of scientific innovation.
Basel, Switzerland's investment landscape is shaped by Biotech & Life Sciences, with 40% of its 5 investment firms focused on this sector. The most active by portfolio size are Syngenta Group Ventures, Kickfund, and MTIP.
Biotech & Life Sciences dominates the investment landscape in Basel, with 40% of investment firms focused on this sector.
Last updated: 28 April 2026
Investment Firms
5
Total Investments
15
Top Sector
Biotech & Life Sciences
Top Stage
Series A
Top Investment Sectors in Basel
The most popular sector focus among Basel investment firms is Biotech & Life Sciences, with 2 investment firms (40%) investing in the space. This is followed by AI (2), Food & Agriculture (1), Fintech (1), Data & Analytics (1).
Investment Stages in Basel
Basel investment firms are most active at the Series A stage (3 investment firms). This is followed by Series C (2), Series D (1), Growth (1), Seed (1).
Syngenta Group Ventures
Basel, Switzerland
6 investments
Series D, Series A
Food & Agriculture, Fintech, Biotech & Life Sciences …
Kickfund
Basel, Switzerland
3 investments
Seed, Series A
Climate & Energy, SaaS, Biotech & Life Sciences
MTIP
Basel, Switzerland
3 investments
Series B, Series C
Healthcare, AI
Wecken & Cie
Basel, Switzerland
2 investments
Travel & Hospitality, Media & Entertainment
Center for Emerging Risk Research
Basel, Switzerland
1 investments
AI